Kemwell Biopharma Pvt. Ltd.
34th KM, Tumkur Road
About Kemwell Biopharma Pvt. Ltd.Kemwell Biopharma Pvt Ltd is located in Bangalore, India and is a pure play contract development and manufacturing service provider for biopharmaceuticals. Kemwell's state-of-the-art facility is one of the largest available capacities for contract manufacturing of monoclonal antibodies and protein therapeutics derived from mammalian cell culture in India.
Founder: Subhash Bagaria
FOLLOW KEMWELL BIOPHARMA:
Tweets by Kemwell Biopharma
4 articles with Kemwell Biopharma Pvt. Ltd.
Ocugen Engages Kemwell Biopharma for cGMP Manufacture of OCU200Paves the way towards getting OCU200 in the clinic by 1H 2022 as planned
Ocugen, Inc. , (NASDAQ: OCGN), a biopharmaceutical company focused on discovering, developing, and commercializing transformative therapies to cure blindness diseases, today announced it has entered into an agreement with Kemwell Biopharma Pvt. Ltd. (Kemwell) to manufacture OCU200 , Ocugen’s novel biologic product candidate in preclinical development for treating severely sight-threatening diseases like Diabetic Macular Edema (DME), Diabetic
Kemwell Biopharma Selected to Manufacture the Monoclonal Antibody Drug Substance For a US Phase 3 Clinical Trial
Kemwell Biopharma, a biologics contract development and manufacturing service provider, announced today that it has signed a contract to manufacture and supply drug substance using its state-of-the-art mammalian cell culture plant in India for Phase 3 clinical trials that will be conducted in the US by its customer for a BLA filing.
Recipharm AB Completes Acquisition Of Kemwell Pharma And Cirrus Pharmaceuticals, Inc. And Resolve On Share Issues